JPH06253878A - Production of lacto-n-biose i and 2-acetamide-2-deoxy-3-o-beta-d-galactopyranosyl-d-galactopyranose - Google Patents
Production of lacto-n-biose i and 2-acetamide-2-deoxy-3-o-beta-d-galactopyranosyl-d-galactopyranoseInfo
- Publication number
- JPH06253878A JPH06253878A JP6761093A JP6761093A JPH06253878A JP H06253878 A JPH06253878 A JP H06253878A JP 6761093 A JP6761093 A JP 6761093A JP 6761093 A JP6761093 A JP 6761093A JP H06253878 A JPH06253878 A JP H06253878A
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- galactosidase
- biose
- lacto
- lactose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、人乳オリゴ糖や複合糖
質などの糖鎖中に含まれ、食品添加物、医薬品、試薬等
として利用可能なラクト−N−ビオースI及び2−アセ
トアミド−2−デオキシ−3−O−β−D−ガラクトピ
ラノシル−D−ガラクトピラノースの製造法に関する。The present invention relates to lacto- N -biose I and 2-acetamide which are contained in sugar chains such as human milk oligosaccharides and complex sugars and can be used as food additives, pharmaceuticals, reagents and the like. It relates to a method for producing 2-deoxy-3- O- β-D-galactopyranosyl-D-galactopyranose.
【0002】[0002]
【従来の技術】ラクト−N−ビオースI(Lacto-N-bios
e I, Galβ1-3GlcNAc )は、ガラクトースとN−アセチ
ルグルコサミンとがβ−1,3結合したオリゴ糖であ
り、2−アセトアミド−2−デオキシ−3−O−β−D
−ガラクトピラノシル−D−ガラクトピラノース(Gal
β1-3GalNAc )は、ガラクトースとN−アセチルガラク
トサミンとがβ−1,3結合したオリゴ糖である。な
お、以下の説明においては、ラクト−N−ビオースIを
「Lacto-N-biose I 」と略記し、2−アセトアミド−2
−デオキシ−3−O−β−D−ガラクトピラノシル−D
−ガラクトピラノースを「Gal β1-3GalNAc 」と略記す
る。BACKGROUND OF THE INVENTION lacto - N - biose I (Lacto- N -bios
e I, Galβ1-3GlcNAc) is an oligosaccharide in which galactose and N -acetylglucosamine are linked by β-1,3, and is 2-acetamido-2-deoxy-3- O- β-D.
-Galactopyranosyl-D-galactopyranose (Gal
β1-3GalNAc) is an oligosaccharide in which galactose and N -acetylgalactosamine are linked by β-1,3. In the following description, lacto - N - a biose I abbreviated as "Lacto- N -biose I", 2-acetamido -2
-Deoxy-3- O- β-D-galactopyranosyl-D
-Galactopyranose is abbreviated as "Gal β1-3GalNAc".
【0003】Lacto-N-biose I 及びGal β1-3GalNAc
は、人乳オリゴ糖や血液型糖タンパク質、リポ多糖、各
種の糖タンパク質及び糖脂質の糖鎖中に存在する生化学
的に非常に重要なオリゴ糖であり、機能性糖などとして
の食品産業上の利用のほか、酵素、レクチンの基質や阻
害剤、生体構成糖など、医薬品、試薬として利用するこ
ともできる。Lacto- N -biose I and Gal β1-3GalNAc
Is a biochemically important oligosaccharide that is present in the sugar chains of human milk oligosaccharides, blood group glycoproteins, lipopolysaccharides, various glycoproteins and glycolipids, and is used as a functional sugar in the food industry. In addition to the above use, it can also be used as a drug or a reagent such as an enzyme, a substrate or inhibitor of a lectin, or a sugar constituting a living body.
【0004】従来、Lacto-N-biose I 及びGal β1-3Gal
NAc は化学合成によって製造されているが、近年、簡便
な方法として、ラクトースと、N−アセチルグルコサミ
ン又はN−アセチルガラクトサミンとを基質として、ウ
シ睾丸(Bovine testes) やラット乳腺(Rat mammary gla
nds)起源のβ−ガラクトシダーゼを作用させる転移反応
を行った後、エッシェリシア・コリ(Escherichia coli)
の生産するβ−ガラクトシダーゼによって副生産物の異
性体を加水分解する製造法が報告されている(Alessand
rini,A. et al. Biol.Chem.1955,220,71. Hedbys,L. e
t al. Glycoconjugate J.1989,6,161.)。Conventionally, Lacto- N- biose I and Gal β1-3Gal
NAc is produced by chemical synthesis. In recent years, as a simple method, lactose and N -acetylglucosamine or N -acetylgalactosamine are used as substrates, and bovine testes (Bovine testes) and rat mammary glands (Rat mammary glas) are used.
nds) The β-galactosidase of the origin is subjected to a transfer reaction, and then Escherichia coli ( Escherichia coli )
A production method of hydrolyzing isomers of by-products by β-galactosidase produced by A.
rini, A. et al. Biol. Chem. 1955, 220, 71. Hedbys, L. e
t al. Glycoconjugate J.1989,6,161.).
【0005】[0005]
【発明が解決しようとする課題】しかしながら、上記簡
便法において、β−ガラクトシダーゼの酵素源として用
いるウシ睾丸やラット乳腺はいずれも希少なため、高価
で入手しにくいという欠点があった。However, in the above-mentioned simple method, the bovine testes and rat mammary glands used as the enzyme source of β-galactosidase are both rare and therefore expensive and difficult to obtain.
【0006】したがって、本発明の目的は、簡便で、安
価に製造が可能なLacto-N-biose I及びGal β1-3GalNAc
の製造法を提供することにある。Therefore, an object of the present invention is to provide Lacto- N- biose I and Gal β1-3GalNAc which are simple and inexpensive to manufacture.
To provide a manufacturing method of.
【0007】[0007]
【課題を解決するための手段】本発明者らは、上記目的
を達成するため、鋭意検討した結果、安価で、大量に入
手可能なブタ睾丸(Porcine testes)起源のβ−ガラクト
シダーゼを用いて、ラクトースと、N−アセチルグルコ
サミン又はN−アセチルガラクトサミンとを基質とし
て、Lacto-N-biose I 又はGal β1-3GalNAc を効率よく
製造できること、及び、安価に市販されているバチルス
・サーキュランス(Bacillus circulans)の生産するβ−
ガラクトシダーゼが、副生産物である異性体及び未反応
のラクトースを選択的に加水分解できることを見いだ
し、本発明を完成するに至った。[Means for Solving the Problems] In order to achieve the above-mentioned objects, the present inventors have conducted extensive studies, and as a result, are inexpensive, and are available in large quantities. Lactose and N -acetylglucosamine or N -acetylgalactosamine as a substrate, Lacto- N- biose I or Gal β1-3GalNAc can be efficiently produced, and inexpensive Bacillus circulans commercially available ( Bacillus circulans ) Β- produced by
It was found that galactosidase can selectively hydrolyze the by-product isomer and unreacted lactose, and completed the present invention.
【0008】すなわち、本発明の一つは、ラクトース
と、N−アセチルグルコサミンとを含有する基質に、ブ
タ睾丸(Porcine testes)起源のβ−ガラクトシダーゼを
作用させてガラクトース転移反応を行わせた後、副生産
物である異性体及び未反応のラクトースを、バチルス・
サーキュランス(Bacillus circulans)の生産するβ−ガ
ラクトシダーゼで加水分解することを特徴とするLacto-
N-biose I の製造法である。That is, one of the present invention is that a substrate containing lactose and N -acetylglucosamine is reacted with β-galactosidase derived from porcine testes to carry out a galactose transfer reaction, By-products such as isomers and unreacted lactose
Lacto- characterized by being hydrolyzed by β-galactosidase produced by circulans ( Bacillus circulans )
N- biose I manufacturing method.
【0009】また、本発明のもう一つは、ラクトース
と、N−アセチルガラクトサミンとを含有する基質に、
ブタ睾丸(Porcine testes)起源のβ−ガラクトシダーゼ
を作用させてガラクトース転移反応を行わせた後、副生
産物である異性体及び未反応のラクトースを、バチルス
・サーキュランス(Bacillus circulans)の生産するβ−
ガラクトシダーゼで加水分解することを特徴とするGal
β1-3GalNAc の製造法である。Another aspect of the present invention is a substrate containing lactose and N -acetylgalactosamine,
After the galactose transfer reaction by acting β-galactosidase of porcine testes (Porcine testes) origin, isomers and unreacted lactose by-products, β produced by Bacillus circulans −
Gal characterized by being hydrolyzed by galactosidase
This is a method for producing β1-3GalNAc.
【0010】以下、本発明について更に詳細に説明す
る。The present invention will be described in more detail below.
【0011】本発明のブタ睾丸(Porcine testes)起源の
β−ガラクトシダーゼは、例えば、ブタ睾丸(Porcine t
estes)の抽出液に、20%飽和となるよう固形硫酸アンモ
ニウムを添加し遠心分離で沈殿を除去したのち、75%飽
和となるよう固形硫酸アンモニウムを添加、塩析し、沈
殿として得られる粗酵素を用いることができる。The β-galactosidase derived from the porcine testes of the present invention is, for example, Porcine t
(estes) extract, add solid ammonium sulfate to 20% saturation and remove the precipitate by centrifugation, then add solid ammonium sulfate to 75% saturation, salt out, and use the crude enzyme obtained as precipitate be able to.
【0012】また、バチルス・サーキュランス(Bacillu
s circulans)の生産するβ−ガラクトシダーゼは、微生
物を培養した培養液に75%飽和になるよう固形硫酸アン
モニウムを添加、溶解し、塩析して得られる粗酵素や、
あるいは、「BIOLACTA」(商品名、大和化成株式会社
製)等の市販酵素を用いることができる。[0012] In addition, Bacillus circulans (Bacillu
β-galactosidase produced by s circulans ) is a crude enzyme obtained by adding solid ammonium sulfate to a culture solution in which a microorganism is cultivated so as to be 75% saturated, dissolving, and salting out,
Alternatively, a commercially available enzyme such as "BIOLACTA" (trade name, manufactured by Daiwa Kasei Co., Ltd.) can be used.
【0013】ガラクトース転移反応に用いるラクトース
と、N−アセチルグルコサミン又はN−アセチルガラク
トサミンとの配合比は、モル比で5:1〜1:10とする
ことが好ましく、かつ、反応液中の全基質濃度を5〜40
重量%として反応を行うことが好ましい。また、ブタ睾
丸(Porcine testes)起源のβ−ガラクトシダーゼは、反
応系において0.03〜0.3 U/mlとなるように添加するの
が好ましい。ガラクトース転移反応は、pH3.5 〜6、
温度30〜50℃で行うことが好ましく、反応時間は50〜15
0 時間が好ましい。The blending ratio of lactose used in the galactose transfer reaction and N -acetylglucosamine or N -acetylgalactosamine is preferably 5: 1 to 1:10 in molar ratio, and all the substrates in the reaction solution are mixed. Concentration 5-40
It is preferable to carry out the reaction as a weight percentage. Further, β-galactosidase derived from porcine testes is preferably added to the reaction system at 0.03 to 0.3 U / ml. The galactose transfer reaction has a pH of 3.5 to 6,
It is preferable to carry out the reaction at a temperature of 30 to 50 ° C and a reaction time of 50 to 15
0 hours is preferred.
【0014】次に、上記反応液を加熱して反応を停止さ
せた後、リン酸緩衝液等を用いて好ましくは10倍程度に
希釈し、バチルス・サーキュランス(Bacillus circulan
s)の生産するβ−ガラクトシダーゼを、好ましくは反応
系において0.50〜2U/ml となるように添加して、上記
反応において副生産物として生じた異性体を加水分解す
る。この加水分解反応は、pH5〜8、温度30〜50℃で
行うことが好ましく、反応時間は、2〜5時間が好まし
い。Then, the reaction solution is heated to stop the reaction, and then diluted with a phosphate buffer or the like, preferably about 10 times, to obtain Bacillus circulan.
The β-galactosidase produced by s ) is added to the reaction system preferably at 0.50-2 U / ml to hydrolyze the isomer produced as a by-product in the above reaction. This hydrolysis reaction is preferably carried out at a pH of 5 to 8 and a temperature of 30 to 50 ° C., and the reaction time is preferably 2 to 5 hours.
【0015】なお、本発明におけるβ−ガラクトシダー
ゼの酵素活性の測定法は、以下のようにして行った。す
なわち、10mMのONP-Gal (オルト−ニトロフェニルガラ
クトシド)溶液0.2ml と、0.1 Mクエン酸緩衝液(pH
4.3 ) 0.5ml又は0.1 Mリン酸緩衝液(pH7.0 ) 0.5
mlと、脱塩水0.2ml を混合し、適当濃度に希釈した酵素
液0.1ml を加え、40℃で反応を行い、1M炭酸ナトリウ
ム0.5ml を加えて反応を停止させた後、オルト−ニトロ
フェノールの吸収である420nm の吸光度を測定した。酵
素活性1Uは1分間に1μmol のオルト−ニトロフェノ
ールを遊離する酵素量と定義した。The method for measuring the enzyme activity of β-galactosidase in the present invention was carried out as follows. That is, 0.2 ml of 10 mM ONP-Gal (ortho-nitrophenylgalactoside) solution and 0.1 M citrate buffer solution (pH
4.3) 0.5 ml or 0.1 M phosphate buffer (pH 7.0) 0.5
ml and deionized water 0.2 ml are mixed, 0.1 ml of enzyme solution diluted to an appropriate concentration is added, the reaction is carried out at 40 ° C., the reaction is stopped by adding 0.5 ml of 1M sodium carbonate, and then ortho-nitrophenol is added. Absorbance at 420 nm was measured. Enzyme activity 1 U was defined as the amount of enzyme that liberates 1 μmol of ortho-nitrophenol in 1 minute.
【0016】本発明の転移反応において、ラクトースと
N−アセチルグルコサミンとを基質とした場合には、La
cto-N-biose I が生成し、ラクトースとN−アセチルガ
ラクトサミンとを基質とした場合には、Gal β1-3GalNA
c が生成する。In the transfer reaction of the present invention, lactose and
When N -acetylglucosamine is used as a substrate, La
When cto- N- biose I is produced and lactose and N -acetylgalactosamine are used as substrates, Gal β1-3GalNA
generated by c.
【0017】上記のようにして得られた反応液は、例え
ば10分間の煮沸により反応を停止した後、生成したLact
o-N-biose I 又はGal β1-3GalNAc を、必要に応じて活
性炭カラムクロマトグラフィー、ゲル濾過、高速液体ク
ロマトグラフィー等の手段を組み合わせて精製すること
ができる。The reaction solution obtained as described above is the Lact formed after the reaction is stopped by boiling for 10 minutes, for example.
O- N- biose I or Gal β1-3GalNAc can be purified by a combination of means such as activated carbon column chromatography, gel filtration, high performance liquid chromatography and the like, if necessary.
【0018】[0018]
【作用】本発明によれば、ラクトースと、N−アセチル
グルコサミン又はN−アセチルガラクトサミンとを基質
とするガラクトース転移反応において、安価で、大量に
入手可能なブタ睾丸(Porcine testes)起源のβ−ガラク
トシダーゼを酵素に使用し、更に、副生産物である異性
体及び未反応のラクトースを加水分解する際に、安価に
市販されている、バチルス・サーキュランス(Bacillus
circulans)の生産するβ−ガラクトシダーゼを用いるこ
とにより、Lacto-N-biose I 及びGal β1-3GalNAc を、
簡便な方法で、安価に製造することができる。INDUSTRIAL APPLICABILITY According to the present invention, in the galactose transfer reaction using lactose and N -acetylglucosamine or N -acetylgalactosamine as substrates, β-galactosidase derived from Porcine testes, which is inexpensive and available in large quantities, is available. Is used as an enzyme, and when hydrolyzing an isomer which is a by-product and unreacted lactose, it is commercially available at a low price, Bacillus circulans ( Bacillus
circulans ) produced β-galactosidase, Lacto- N- biose I and Gal β1-3GalNAc,
It can be manufactured inexpensively by a simple method.
【0019】[0019]
実施例1 ラクトース20gとN−アセチルグルコサミン5g(モル
比2:1)を50mMクエン酸緩衝液(pH4.3 )に溶解
し、100ml 溶液とした。この溶液に、ブタ睾丸(Porcine
testes)起源のβ−ガラクトシダーゼを14U添加し、40
℃で100 時間反応を行い、10分間の煮沸により反応を停
止した。高速液体クロマトグラフィーによる分析の結
果、主生成物としてLacto-N-biose I とN−アセチルラ
クトサミン(Gal β1-4GlcNAc )を得た。なお、高速液
体クロマトグラフィーの分析条件は下記の通りである。Example 1 20 g of lactose and 5 g of N -acetylglucosamine (molar ratio 2: 1) were dissolved in a 50 mM citrate buffer solution (pH 4.3) to prepare a 100 ml solution. To this solution, add the testicles of Porcine (Porcine
testes) β-galactosidase of 14 U was added, and
The reaction was performed at 100 ° C for 100 hours, and the reaction was stopped by boiling for 10 minutes. As a result of analysis by high performance liquid chromatography, Lacto- N- biose I and N -acetyllactosamine (Gal β1-4GlcNAc) were obtained as main products. The analysis conditions for high performance liquid chromatography are as follows.
【0020】カラム:Asahipak NH2P-50(商品名、旭化
成工業株式会社製) (4.6 ×250 mm) 移動相:アセトニトリル:水=75:25 流 速:1ml/min 温 度:40℃ 検 出:UV 210nm 試 料:10μlColumn: Asahipak NH2P-50 (trade name, manufactured by Asahi Kasei Corporation) (4.6 x 250 mm) Mobile phase: acetonitrile: water = 75:25 Flow rate: 1 ml / min Temperature: 40 ° C Detection: UV 210nm sample: 10μl
【0021】そしてこの反応液を50mMリン酸緩衝液(p
H7.0 )を用いて10倍希釈し、バチルス・サーキュラン
ス(Bacillus circulans)の生産するβ−ガラクトシダー
ゼを950 U添加して、40℃で3.5 時間反応を行い、10分
間の煮沸により反応を停止した。この反応により、基質
であるラクトースやN−アセチルラクトサミン(Galβ1
-4GlcNAc )、N−アセチルアロラクトサミン(Gal β1
-6GlcNAc )が選択的に加水分解された。Then, this reaction solution was mixed with 50 mM phosphate buffer (p
Dilute 10 times with H7.0), add 950 U of β-galactosidase produced by Bacillus circulans , react at 40 ° C for 3.5 hours, and stop the reaction by boiling for 10 minutes. did. By this reaction, the substrate lactose and N -acetyllactosamine (Galβ1
-4GlcNAc), N -acetyl allolactosamine (Gal β1
-6GlcNAc) was selectively hydrolyzed.
【0022】こうして得られた反応液を脱塩水で平衡化
した活性炭カラム(2.4 ×96cm)に供した。非吸着部を
脱塩水で洗浄後、3%エタノール溶液16L(リットル)
で基質であるN−アセチルグルコサミンを溶出し、続い
て3〜20%エタノール溶液の直線濃度勾配により目的生
成物であるLacto-N-biose I を溶出、分離した。更にこ
の画分を濃縮後、メタノールにより結晶化を行ったとこ
ろ、本反応により536mgのLacto-N-biose I が製造され
た。The reaction solution thus obtained was applied to an activated carbon column (2.4 × 96 cm) equilibrated with demineralized water. After washing the non-adsorbed part with demineralized water, 3% ethanol solution 16 L (liter)
The substrate, N -acetylglucosamine, was eluted with the following procedure, and then the target product, Lacto- N- biose I, was eluted and separated by a linear concentration gradient of a 3 to 20% ethanol solution. Further, this fraction was concentrated and then crystallized with methanol. As a result, 536 mg of Lacto- N- biose I was produced by this reaction.
【0023】実施例2 ラクトース20gとN−アセチルガラクトサミン5g(モ
ル比2:1)を50mMクエン酸緩衝液(pH4.3 )に溶解
し、100ml 溶液とした。この溶液に、ブタ睾丸(Porcine
testes)起源のβ−ガラクトシダーゼを14U添加し、40
℃で100 時間反応を行った。10分間の煮沸により反応を
停止した後、この反応液を50mMリン酸緩衝液(pH7.0
)を用いて10倍希釈し、バチルス・サーキュランス(Ba
cillus circulans)の生産するβ−ガラクトシダーゼを
950U添加して、40℃で3.5 時間反応を行った。10分間
の煮沸により反応を停止した後、得られた反応液を実施
例1と同様の条件で活性炭カラムに供し、Gal β1-3Gal
NAc を分離、精製した。その結果、本反応により444mg
のGal β1-3GalNAc が結晶として製造された。Example 2 20 g of lactose and 5 g of N -acetylgalactosamine (molar ratio 2: 1) were dissolved in a 50 mM citrate buffer (pH 4.3) to prepare a 100 ml solution. To this solution, add the testicles of Porcine (Porcine
testes) β-galactosidase of 14 U was added, and
The reaction was carried out at 100 ° C for 100 hours. After stopping the reaction by boiling for 10 minutes, the reaction solution was added to 50 mM phosphate buffer (pH 7.0).
) With Bacillus circulans ( Ba
β-galactosidase produced by cillus circulans )
After adding 950 U, the reaction was carried out at 40 ° C. for 3.5 hours. After the reaction was stopped by boiling for 10 minutes, the obtained reaction solution was subjected to an activated carbon column under the same conditions as in Example 1 to give Gal β1-3Gal.
NAc was separated and purified. As a result, this reaction caused 444 mg.
Gal β1-3GalNAc was produced as a crystal.
【0024】[0024]
【発明の効果】以上説明したように、本発明によれば、
人乳オリゴ糖や血液型糖タンパク質、リポ多糖、各種の
糖タンパク質及び糖脂質の糖鎖中に含まれ、生化学的に
極めて重要なオリゴ糖であるLacto-N-biose I 及びGal
β1-3GalNAc を、簡便な方法で、安価に製造することが
可能になる。これらのオリゴ糖は、食品添加物、医薬
品、試薬などとして利用することができる。As described above, according to the present invention,
Lacto- N- biose I and Gal are oligosaccharides that are extremely important in biochemistry and are contained in the sugar chains of human milk oligosaccharides, blood group glycoproteins, lipopolysaccharides, various glycoproteins and glycolipids.
β1-3GalNAc can be produced inexpensively by a simple method. These oligosaccharides can be used as food additives, pharmaceuticals, reagents and the like.
Claims (2)
ンとを含有する基質に、ブタ睾丸(Porcine testes)起源
のβ−ガラクトシダーゼを作用させてガラクトース転移
反応を行わせた後、副生産物である異性体及び未反応の
ラクトースを、バチルス・サーキュランス(Bacillus ci
rculans)の生産するβ−ガラクトシダーゼで加水分解す
ることを特徴とするラクト−N−ビオースIの製造法。1. An isomer which is a by-product after a β-galactosidase derived from porcine testes (Porcine testes) is allowed to act on a substrate containing lactose and N -acetylglucosamine to cause a galactose transfer reaction. and lactose of unreacted, Bacillus circulans (Bacillus ci
rculans ) -produced lacto- N -biose I, which comprises hydrolyzing with β-galactosidase.
ミンとを含有する基質に、ブタ睾丸(Porcine testes)起
源のβ−ガラクトシダーゼを作用させてガラクトース転
移反応を行わせた後、副生産物である異性体及び未反応
のラクトースを、バチルス・サーキュランス(Bacillus
circulans)の生産するβ−ガラクトシダーゼで加水分解
することを特徴とする2−アセトアミド−2−デオキシ
−3−O−β−D−ガラクトピラノシル−D−ガラクト
ピラノースの製造法。2. An isomer which is a by-product after a β-galactosidase derived from porcine testes is allowed to act on a substrate containing lactose and N -acetylgalactosamine to cause a galactose transfer reaction. and lactose of unreacted, Bacillus circulans (Bacillus
circulans ) -producing β-galactosidase for hydrolysis of 2-acetamido-2-deoxy-3- O- β-D-galactopyranosyl-D-galactopyranose.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6761093A JPH06253878A (en) | 1993-03-03 | 1993-03-03 | Production of lacto-n-biose i and 2-acetamide-2-deoxy-3-o-beta-d-galactopyranosyl-d-galactopyranose |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6761093A JPH06253878A (en) | 1993-03-03 | 1993-03-03 | Production of lacto-n-biose i and 2-acetamide-2-deoxy-3-o-beta-d-galactopyranosyl-d-galactopyranose |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH06253878A true JPH06253878A (en) | 1994-09-13 |
Family
ID=13349891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6761093A Ceased JPH06253878A (en) | 1993-03-03 | 1993-03-03 | Production of lacto-n-biose i and 2-acetamide-2-deoxy-3-o-beta-d-galactopyranosyl-d-galactopyranose |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH06253878A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001292793A (en) * | 2000-04-13 | 2001-10-23 | Nippon Shokuhin Kako Co Ltd | METHOD FOR PRODUCING p-NITROPHENYL-beta-PRIMEVEROSIDE CRYSTAL |
WO2008078614A1 (en) | 2006-12-22 | 2008-07-03 | Incorporated Administrative Agency National Agriculture And Food Research Organization | Method for producing lacto-n-biose i or galacto-n-biose |
JP2008290972A (en) * | 2007-05-24 | 2008-12-04 | National Agriculture & Food Research Organization | Selective proliferation promoter for bacillus bifidus |
WO2011096360A1 (en) | 2010-02-05 | 2011-08-11 | 森永乳業株式会社 | Method for treatment of lacto-n-biose-containing solution |
CN114990175A (en) * | 2021-10-22 | 2022-09-02 | 岩唐生物科技(杭州)有限责任公司 | Synthesis method of fucose derivatives |
WO2024101286A1 (en) * | 2022-11-11 | 2024-05-16 | 雪印メグミルク株式会社 | N-acetyllactosamine production method and n-acetyllactosamine-containing composition |
-
1993
- 1993-03-03 JP JP6761093A patent/JPH06253878A/en not_active Ceased
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001292793A (en) * | 2000-04-13 | 2001-10-23 | Nippon Shokuhin Kako Co Ltd | METHOD FOR PRODUCING p-NITROPHENYL-beta-PRIMEVEROSIDE CRYSTAL |
WO2008078614A1 (en) | 2006-12-22 | 2008-07-03 | Incorporated Administrative Agency National Agriculture And Food Research Organization | Method for producing lacto-n-biose i or galacto-n-biose |
JP2008290972A (en) * | 2007-05-24 | 2008-12-04 | National Agriculture & Food Research Organization | Selective proliferation promoter for bacillus bifidus |
WO2011096360A1 (en) | 2010-02-05 | 2011-08-11 | 森永乳業株式会社 | Method for treatment of lacto-n-biose-containing solution |
US9060529B2 (en) | 2010-02-05 | 2015-06-23 | Morinaga Milk Industry Co., Ltd. | Method for treatment of lacto-N-biose-containing solution |
CN114990175A (en) * | 2021-10-22 | 2022-09-02 | 岩唐生物科技(杭州)有限责任公司 | Synthesis method of fucose derivatives |
WO2024101286A1 (en) * | 2022-11-11 | 2024-05-16 | 雪印メグミルク株式会社 | N-acetyllactosamine production method and n-acetyllactosamine-containing composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Corfield et al. | The release of N-acetyl-and N-glycolloyl-neuraminic acid from soluble complex carbohydrates and erythrocytes by bacterial, viral and mammalian sialidases | |
Lowe et al. | Lysozyme-catalysed hydrolysis of some β-aryl di-N-acetylchitobiosides | |
Nelsestuen et al. | The carbohydrate of bovine prothrombin: Partial structural determination demonstrating the presence of α-galactose residues | |
JP3131655B2 (en) | Method for producing N-acetylneuraminic acid | |
Song et al. | Improvement of lactulose synthesis through optimization of reaction conditions with immobilized β-galactosidase | |
Sheares et al. | Characterization of UDP-galactose: 2-acetamido-2-deoxy-D-glucose 3 beta-galactosyltransferase from pig trachea. | |
JPH06253878A (en) | Production of lacto-n-biose i and 2-acetamide-2-deoxy-3-o-beta-d-galactopyranosyl-d-galactopyranose | |
Magee et al. | Proteolytic conversion of the molecular forms of bovine milk galactosyltransferase | |
Yamashita et al. | Structural study of the sugar chains of α-amylases produced ectopically in tumors | |
JPH0349692A (en) | Production of n-acetyllactosamine | |
JPH0349693A (en) | Production of n-acetyllactosamine | |
CN105177085B (en) | A kind of single-minded application for turning glycosyl alpha-galactosidase of regioselectivity | |
Erickson et al. | Interaction of purified brush-border membrane aminopeptidase N and dipeptidyl peptidase IV with lectin-sepharose derivatives | |
Sutherland et al. | The Isolation of O‐Acetylated Fragments from the K Antigen of Escherichia coli 08: K27 (A): H by the Action of Phage‐Induced Enzymes from Klebsiella aerogenes | |
JP3002113B2 (en) | Method for producing carbohydrate or complex carbohydrate | |
SCHAUER et al. | Isolation and characterization of a sialidase from the starfish Asterias rubens | |
JP3105306B2 (en) | Method for producing carbohydrate or complex carbohydrate | |
JP4109343B2 (en) | Process for producing β-1,4-galactosyl-maltose | |
JP3045509B2 (en) | Method for producing mannose-containing oligosaccharides | |
JP3100012B2 (en) | Novel neuraminidase, method for producing the same, and method for producing sialic acid binding compound using the same | |
Goso et al. | Purification and characterization of α-l-fucosidases from Streptomyces sp. OH11242 | |
Roy et al. | The sulphatase of ox liver: XXIV. The glycosulphatase activity of sulphatase a | |
JP3691900B2 (en) | Production method of carbohydrate | |
JP3041657B2 (en) | Novel β1 → 3-N-acetylglucosaminyltransferase, method for producing the same, and method for producing N-acetylglucosaminyltransfer product | |
Omichi et al. | Studies on the Substrate Specificity of Taka-amylase A V. An Inspection of the Active Site of the Enzyme Utilizing Transfer Reaction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20040713 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20040913 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20070810 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20080825 |
|
A045 | Written measure of dismissal of application |
Effective date: 20090224 Free format text: JAPANESE INTERMEDIATE CODE: A045 |